Skip to main content

Table 2 Model information of prognostic mRNAs

From: Two precision medicine predictive tools for six malignant solid tumors: from gene-based research to clinical application

Gene

Univariate analysis

Multivariate analysis

HR

95% CI

P-value

Coefficient

HR

95% CI

P-value

ENDOU

0.642

0.425–0.972

0.036

− 4.273

0.014

0.004–0.047

< 0.001

MFN2

0.632

0.417–0.957

0.030

− 1.489

0.226

0.125–0.408

< 0.001

FASLG

0.560

0.368–0.853

0.007

− 1.243

0.288

0.098–0.846

0.024

SHOC2

1.544

1.023–2.333

0.039

− 0.904

0.405

0.179–0.917

0.030

VEGFA

1.569

1.037–2.373

0.033

− 0.834

0.434

0.226–0.833

0.012

ZFPM2

1.805

1.183–2.753

0.006

− 0.690

0.501

0.363–0.693

< 0.001

HOXC6

1.567

1.037–2.368

0.033

0.249

1.283

1.064–1.547

0.009

KLK10

1.593

1.053–2.409

0.028

0.446

1.562

1.161–2.100

0.003

DDIT4

1.710

1.126–2.596

0.012

0.672

1.959

1.319–2.908

0.001

LPGAT1

1.570

1.039–2.371

0.032

0.705

2.023

1.199–3.415

0.008

BEX4

1.795

1.185–2.721

0.006

0.711

2.036

1.521–2.725

< 0.001

DENND5B

1.527

1.010–2.308

0.045

1.038

2.824

1.155–6.909

0.023

PHF20L1

1.562

1.028–2.373

0.037

1.065

2.901

1.162–7.241

0.022

HSP90B1

1.959

1.291–2.972

0.002

1.093

2.982

1.561–5.696

0.001

PSPC1

1.863

1.228–2.825

0.003

1.146

3.144

1.682–5.877

< 0.001

  1. HR hazard ratio, CI confidence interval
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us